View in EDS HTML Full Text PDF Full Text

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.

Saved in:
Bibliographic Details
Title: Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.
Authors: Aghemo, Alessio1,2 (AUTHOR) alessio.aghemo@hunimed.eu, Persico, Marcello3 (AUTHOR), D'Ambrosio, Roberta4 (AUTHOR), Andreoni, Massimo5 (AUTHOR), Villa, Erica6 (AUTHOR), Bhagat, Abhi7 (AUTHOR), Gallinaro, Valentina8 (AUTHOR), Gualberti, Giuliana8 (AUTHOR), Merolla, Rocco Cosimo Damiano8 (AUTHOR), Gasbarrini, Antonio9 (AUTHOR)
Source: PLoS ONE. 2/2/2023, Vol. 18 Issue 2, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0280165